A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma

INTRODUCTION: Radiofrequency ablation (RFA) is the foremost treatment option for advanced hepatocellular carcinoma (HCC), however, rapid and aggressive recurrence of HCC often occurs after RFA due to epithelial–mesenchymal transition process. Although combination of RFA with sorafenib, a molecular t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Hui, Tian, Shengtao, Yu, Haipeng, Yang, Xueling, Liu, Jia, Wang, Huaming, Feng, Fan, Guo, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987756/
https://www.ncbi.nlm.nih.gov/pubmed/29910621
http://dx.doi.org/10.2147/OTT.S165000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987756/
https://www.ncbi.nlm.nih.gov/pubmed/29910621
http://dx.doi.org/10.2147/OTT.S165000

Ejemplares similares